23. Symposium of the AGNP

Abstracts (HTML) List of Authors

Maccarrone, G.

Analysis of cerebrospinal fluid of depressed patients

Mager, T.

D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Mahlberg, R.

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Mahlke, K.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Maier, W.

Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride
Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls
CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?
Pharmacogenetic methods for rational drug choice
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Majer, M.

Neuropsychological deficits and long-term outcomes in patients with affective disorders
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy

Maler, M.

Neurochemical early and differential diagnosis of Alzheimer’s dementia

Mann, K.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Relapse and gender specific activation of the striatum in alcohol dependent patients

Marcus, R.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania

Marmar, C. R.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Marocco, J.

Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)

Marques, C. A.

Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway

Marsicano, G.

The roles of the endogenous cannabinoid system in learning and memory in mice

Martin, M.

Genetic aspects of antipsychotic induced body weight change

Martin, P.

Different aspects of executive function in first episode schizophrenia

Mass, R.

The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study

Mathias, S.

Nocturnal ghrelin levels in normal controls – effects of gender
Ghrelin promotes slow-wave sleep in man
Modulation of GABAergic systems with GABA agonists and antagonists, effects on sleep EEG and hormone secretion
GHRH impairs sleep in normal females

Matthies, U.

Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients

Maurer, C.

Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital

Mavrogiorgou, P.

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Mayer, G.

Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Mazziotta, J. C.

Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study

Meichel, K.

Hippocampal volume reduction and HPA-system activity in major depression

Meier, A.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects

Meisenzahl, E. M.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics

Meitinger, T.

Evidence for genetic heterogeneity in Restless Legs Syndrome

Mendes, C. T.

Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons

Meraner, V.

Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?

Mergl, R.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients

Messer, T.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Metten, M.

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?

Metzler, T. J.

Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder

Meyer-Lindenberg, A.

Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls

Michael, N.

High basal prolactin values predict response to reboxetine treatment in major depression
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test

Michel, K.

New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice

Michelson, D.

Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder
Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder

Milfay, D.

Validation of a genetic mouse model for anxiety and comorbid depression

Minov, C.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Mirowska, D.

Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone

Missler, U.

Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B

Mobascher, A.

Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs

Modell, S.

Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania
Neuropsychological deficits and long-term outcomes in patients with affective disorders
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
The effects of RS-86 on sleep with respect to depression and HLA-type
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?

Moeller, O.

High basal prolactin values predict response to reboxetine treatment in major depression
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test

Moller, H. J.

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

Möller, H. J.

Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients
A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
Systematic screen of serotonergic genes in suicidal behaviour
A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Association study of SNPs in G72 and DAAO in schizophrenia
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Neural representation of cognitive changes within the visual system in the AD brain

Möller-Hartmann, W.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies

Monory, K.

The roles of the endogenous cannabinoid system in learning and memory in mice

Morgenthaler, N.

Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease

Mossiaguine, I.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis

Mössner, R.

An organic cation transporter capable of transporting serotonin is upregulated in serotonin transporter-deficient mice

Mueller-Oerlinghausen, B.

IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis

Mulert, C.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity

Müller, B. W.

The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram

Müller, J.

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Müller, J. L.

Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses

Müller, K. M.

Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital

Müller, M. B.

Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders

Müller, M. J.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Therapeutic drug monitoring (TDM) of quetiapine
Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital
Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?
The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects

Müller, W. E.

Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity
Activation of nonselective cation channels by hyperforin – A novel mechanism of antidepressant activity
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner

Müller-Myhsok, B.

HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Evidence for genetic heterogeneity in Restless Legs Syndrome
Is there a genetic continuum between anxiety and depression?

Müller-Oerlinghausen, B.

The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects

Müller-Siecheneder, F.

Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Long term electroconvulsive treatment as maintenance and prophylactic therapy of affective disorders
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Müller-Spahn, F.

Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol

Murck, H.

Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression
Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium
Magnesium-deficient diet alters depression and anxiety-related behavior in mice – Influence of desipramine and hypericum extract
Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression

Murgatroyd, C.

Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP